ArticleFoods (Basel, Switzerland)2025
Using Volatile Oxidation Products to Predict the Inflammatory Capacity of Oxidized Methyl Linoleate.
Article in Foods (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
This study evaluated whether the volatile profile of methyl linoleate (MLO) can predict its pro-inflammatory capacity. MLO was subjected to two oxidation conditions simulating ambient storage and high-temperature frying. Free radicals, volatile compounds, and aldehydes were quantified using ESR, HS-SPME-GC-MS, and UPLC-MS/MS. Oxidized MLO was applied to RAW264.7 macrophages to evaluate inflammatory cytokines and oxidative stress responses, and PLSR models were developed to predict cellular outcomes based on volatile fingerprints. Both oxidation conditions induced substantial increases in short-chain and unsaturated aldehydes, with high-temperature oxidation generating markedly higher levels of key volatiles. Oxidized MLO significantly elevated TNF-α, IL-1β, COX-2, ROS, NO, and MDA while reducing SOD activity (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.